Monthly Archives: July 2013

Reconstituted CRP determines complaints against 20 Swisse products

As requested by the Federal Court, a reconstituted CRP considered again complaints 2011-11-001 and 2011-11-009 about a number of Swisse Products. In a 71 page judgement published on 4 June 2013, twenty television advertisements were reviewed for the following products: … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , , , | Leave a comment

How well does Australia control the promotion of therapeutic goods?

Yesterday, I gave an invited presentation to TGA staff in Canberra (and elsewhere by video-link).  I reviewed how well Australia had implemented the 2007 World Health Assembly’s (WHA) Resolution 60.16: “Wishing to promote evidence-based rational use of medicines by providers and consumers, … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , , , , | 1 Comment

CRP and TGA retraction orders revoked by AAT

In December 2010 I complained about a number of claims made in advertisements for Ethical Nutrients “Urinary Tract Support”. These included: “Urinary Tract Support contains a combination of herbs which effectively relieve the symptoms of urinary tract infections such as cystitis”. … Continue reading

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , , , , , , , | Leave a comment

Latest Nurofen complaint sent to TGA because of non-compliance

As predicted, Reckitt Benckiser (Australia) Pty Ltd have ignored the latest CRP determination. Their non-compliance has now been referred to the TGA for a Regulation 9 order.  It remains to be seen what effect this will have. To my knowledge, since November 2010 … Continue reading

Posted in Uncategorized | Leave a comment

Omega 3 & Prostate Cancer

The Complementary Healthcare Council of Australia (CHC) says a study recently published in the Journal of the National Cancer Institute linking Omega-3 intake with prostate cancer is inconclusive and contradictory of a large pool of pre-existing, robust evidence that demonstrates … Continue reading

Posted in Complementary medicine | Tagged , , , | Leave a comment

MJA Insight: Published:Advertising battleground

Published: https://www.mja.com.au/insight/2013/26/ken-harvey-advertising-battleground by

Posted in Complementary medicine, Natural Therapies, Pharmaceutical Promotion | Tagged , | Leave a comment

CRP upholds complaints (again) about Nurofen “targeted relief”

For a nice depiction of the claims (and their craziness) see: ABC TV The Checkout: Episode 5 Also: https://theconversation.com/tga-failure-gives-nurofen-consumers-a-headache-8762 And: https://theconversation.com/targeted-pain-relief-or-targeted-marketing-the-truth-hurts-13798 The CRP’s determination is available here. A summary follows: Complaints 2012-08-010 and 2012-10-024: Nurofen Back Pain, Nurofen Migraine Pain, Nurofen Period … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , | Leave a comment

Medicines Australia Transparency Working Group Releases Reports

The documents, “Principles for transparency” and “Transparency model consultation and discussion document” are now available. For comment see: Harvey K. Slow path to transparency. MJA Insight, July 1, 2013. https://www.mja.com.au/insight/2013/24/ken-harvey-slow-path-transparency Coleman J. GPs will gain from greater transparency. 6 Minutes Q&A, July … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , | Leave a comment